Allopurinol/Benzbromarone

别嘌呤/苯溴马隆

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAllopurinol/Benzbromarone
Drug Alias Name复方别嘌醇片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitorsCytochrome P450 2C9 inhibitors
TargetsXanthine dehydrogenaseCytochrome P450 2C9
Therapy Area/IndicationsHyperuricemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AllopurinolBenzbromarone
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHyperuricemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A